Stockholders' Equity (Tables)

12 Months Ended

Sep. 30, 2019

Schedule of stock compensation expense

Stock compensation expense is recorded in general and administrative expenses and is presented below for the years ended September 30, 2019 and 2018:

	2019		2018
Stock Grants	$	282,000	$	287,000
Restricted Stock Grants		34,000		55,000
Option Grants		—		17,000
Employee Stock Purchase Plan		3,000		3,000
Subsidiary Option Grants		43,000		95,000
Total	$	362,000	$	457,000

Schedule of restricted stock activity

A summary of restricted stock activity for the years ended September 30, 2019 and 2018 is presented below:

Restricted Stock Activity for the Year ended		Weighted-Average
September 30, 2019	Shares	Grant-Date Fair Value
Nonvested at September 30, 2018	60,000	$	1.61
Granted	—
Vested	(35,000)	$	1.68
Cancelled	(10,000)		1.70
Nonvested and expected to vest at September 30, 2019	15,000	$	1.37

Restricted Stock Activity for the Year ended		Weighted-Average
September 30, 2018	Shares	Grant-Date Fair Value
Nonvested at September 30, 2017	70,000	$	1.73
Granted	20,000	$	1.37
Vested	(30,000)	$	1.73
Cancelled	—		—
Nonvested and expected to vest at September 30, 2018	60,000	$	1.61

Stock Option Grants [Member]

Schedule of stock option activity

A summary of stock option activity for the years ended September 30, 2019 and 2018 is presented below:

				Weighted Average
			Weighted Average	Remaining
	Options		Exercise Price per	Contractual Term
	Outstanding		Share	(in Years)
Balance at September 30, 2017	196,769	$	1.98	1.64
Outstanding and exercisable at September 30, 2017	196,769	$	1.98	1.64
Granted	—		—
Exercised	—		—
Cancelled	(36,232)		1.82
Balance at September 30, 2018	160,537	$	2.01	0.93
Outstanding and exercisable at September 30, 2018	160,537	$	2.01	0.93
Granted	—		—
Exercised	—		—
Cancelled	(64,935)		2.33
Balance at September 30, 2019	95,602	$	1.80	0.34
Outstanding and exercisable at September 30, 2019	95,602	$	1.80	0.34

Subsidiary Option Grants [Member]

Schedule of stock option activity

A summary of Xcede stock option activity for the years ended September 30, 2019 and 2018 is presented below:

			Weighted Average
		Weighted Average	Remaining
	Options	Exercise Price per	Contractual Term
	Outstanding	Share ($)	(in Years)
Balance,expected to vest,at September 30, 2017	1,375,956	1.00	8.70
Outstanding and exercisable at September 30, 2017	923,617	1.00	8.30
Granted	—	—
Exercised	—	—
Cancelled	(75,000)	1.00
Balance,expected to vest,at September 30, 2018	1,300,956	1.00	7.31
Outstanding and exercisable at September 30, 2018	1,229,685	1.00	7.11
Granted	—	—
Exercised	—	—
Cancelled	—	—
Balance,expected to vest,at September 30, 2019	1,300,956	1.00	6.10
Outstanding and exercisable at September 30, 2019	1,300,956	1.00	6.10